Home » Newsletters » BioWorld Science

BioWorld Science

March 17, 2022

View Archived Issues

NLRP4 mutations predict anti-PD-L1 treatment response in patients with NSCLC

Shengke Pharmaceuticals discovers FLT inhibitors

New lysine-specific demethylase 5B inhibitors identified at FibroGen

New G protein-coupled receptor 52 agonists synthesized at Heptares Therapeutics

Sichuan Good Doctor Panxi Pharmaceutical describes new wound-healing polypeptides

TIMP-1 and CKM are biomarkers of treatment response in DMD

New rat model may shed light on mechanisms behind CSVD pathogenesis

New GSK-3 inhibitors patented by Ramot at Tel Aviv University, Bar-Ilan University

RGX-202 improves muscle function and dystrophic muscle pathology in mice

Blood stem cells treat brain disease after transplant

Discovery of novel S1PR2 ligands as tracers for neuroimaging

PepGen presents promising preclinical data for PGN-EDO51

ETC-642 increases plasma HDL and protects mice from sepsis

Sanofi and Seagen to develop and commercialize antibody-drug conjugates for cancer targets

Oppilotech partners with Evariste on first-in-class antibacterial program

Sareum receives final preclinical toxicology report for SDC-1801

In vivo pharmacokinetic data confirm BETR-001 bioavailability in target brain tissue

Popular Stories

News in brief
BioWorld Asia
BioWorld Asia briefs for April 28, 2026
Chinese biotechs gain leverage as partners in dealmaking
BioWorld
China’s biotech ecosystem has crossed an inflection point, and Chinese biotechs are gaining leverage in dealmaking, executives from multinational companies said...
Bio Korea 2026 kicks off with spotlight on oligonucleotides
BioWorld
Three decades of trial-and-error, and the resulting safety data, in the oligonucleotide-based therapeutic space have paved way for the present-day innovations and...
Roche identifies new TREM2 agonists
BioWorld Science
F. Hoffmann-La Roche Ltd. and Hoffmann-La Roche Inc. have prepared and tested new compounds acting as triggering receptor expressed on myeloid cells 2 (TREM2)...
Plasticity, properly parsed, provides psychiatric platform
BioWorld
If Benjamin Braddock, of The Graduate fame, were a young neuroscientist in the 21st century instead of a liberal arts graduate in 1967, the advice he received...